Go Pro

Barrow Hanley Mewhinney & Strauss LLC Takes Position in Novanta Inc. $NOVT

Novanta logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Barrow Hanley Mewhinney & Strauss LLC acquired 440,131 Novanta shares worth approximately $71.4 million, giving it a 1.16% stake. Institutional investors collectively own 98.35% of NOVT.
  • Novanta reported quarterly EPS of $0.89, exceeding the $0.83 consensus estimate, while revenue rose 10.3% year over year to $265.8 million. The company issued fiscal 2026 EPS guidance of $3.68–$3.74.
  • Analyst sentiment is generally positive, with a consensus “Buy” rating and a $194 price target. CEO Matthijs Glastra separately sold 6,500 shares under a pre-arranged Rule 10b5-1 trading plan.
  • Interested in Novanta? Here are five stocks we like better.

Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 440,131 shares of the technology company's stock, valued at approximately $71,407,000. Barrow Hanley Mewhinney & Strauss LLC owned 1.16% of Novanta as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in NOVT. Allspring Global Investments Holdings LLC lifted its position in Novanta by 27.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,776,694 shares of the technology company's stock valued at $210,307,000 after purchasing an additional 377,232 shares during the period. Conestoga Capital Advisors LLC raised its stake in shares of Novanta by 3.4% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,458,259 shares of the technology company's stock worth $173,518,000 after buying an additional 47,540 shares in the last quarter. State Street Corp raised its stake in shares of Novanta by 1.0% during the 4th quarter. State Street Corp now owns 1,319,474 shares of the technology company's stock worth $157,004,000 after buying an additional 13,603 shares in the last quarter. Wasatch Advisors LP lifted its holdings in shares of Novanta by 10.6% in the 2nd quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company's stock valued at $141,827,000 after buying an additional 104,985 shares during the period. Finally, Bamco Inc. NY lifted its holdings in shares of Novanta by 49.4% in the 4th quarter. Bamco Inc. NY now owns 936,962 shares of the technology company's stock valued at $111,489,000 after buying an additional 309,869 shares during the period. 98.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the company's stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total value of $1,047,345.00. Following the sale, the chief executive officer owned 29,761 shares of the company's stock, valued at $4,795,389.93. This represents a 17.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

NOVT has been the topic of a number of recent analyst reports. Zacks Research raised Novanta from a "hold" rating to a "strong-buy" rating in a report on Friday, August 14th. Weiss Ratings reissued a "hold (c-)" rating on shares of Novanta in a report on Wednesday, July 15th. Wall Street Zen upgraded shares of Novanta from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Finally, Robert W. Baird set a $194.00 price target on shares of Novanta in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $194.00.

Read Our Latest Analysis on Novanta

Novanta Price Performance

Novanta stock opened at $145.24 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.79 and a current ratio of 4.57. The firm has a market capitalization of $5.49 billion, a price-to-earnings ratio of 93.10 and a beta of 1.68. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $176.38. The stock's fifty day moving average is $153.52 and its two-hundred day moving average is $143.20.

Novanta (NASDAQ:NOVT - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The technology company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.06. Novanta had a return on equity of 10.83% and a net margin of 6.00%.The business had revenue of $265.81 million during the quarter, compared to the consensus estimate of $262.30 million. During the same quarter in the previous year, the company posted $0.76 EPS. The business's revenue was up 10.3% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. Analysts predict that Novanta Inc. will post 3.7 EPS for the current fiscal year.

About Novanta

(Free Report)

Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

See Also

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines